Raymond James Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $137
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) and increased the price target from $133 to $137.
January 03, 2024 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst Jayson Bedford has reaffirmed an Outperform rating on Zimmer Biomet Holdings and raised the price target to $137.
The increase in price target by Raymond James reflects a positive outlook on Zimmer Biomet Holdings, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100